Development of an Allogeneic TAC Gamma Delta T Cell Immunotherapy Program
Time: 12:30 pm
day: Day Two
Details:
- Donor screening and selection
- Assay development and qualification
- Manufacturing for Phase I Clinical Studies
Time: 12:30 pm
day: Day Two
Details: